The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC 157 Legal? Understanding Its Status and Implications FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC FDA Peptide Reclassification 2026: What It Means for Providers